Compare UFI & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UFI | ZTEK |
|---|---|---|
| Founded | 1969 | 2008 |
| Country | United States | Canada |
| Employees | 2700 | N/A |
| Industry | Textiles | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.3M | 78.2M |
| IPO Year | N/A | N/A |
| Metric | UFI | ZTEK |
|---|---|---|
| Price | $4.07 | $0.68 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 62.2K | ★ 108.0K |
| Earning Date | 02-03-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $542,134,000.00 | $657,134.00 |
| Revenue This Year | $1.39 | N/A |
| Revenue Next Year | $12.57 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2225.73 |
| 52 Week Low | $2.96 | $0.62 |
| 52 Week High | $6.03 | $1.84 |
| Indicator | UFI | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 57.70 | 41.25 |
| Support Level | $3.96 | $0.62 |
| Resistance Level | $4.63 | $0.72 |
| Average True Range (ATR) | 0.19 | 0.07 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 38.56 | 17.60 |
Unifi Inc is a multi-national company. It manufactures and sells synthetic and recycled products made from polyester and nylon predominantly to other yarn manufacturers and knitters and weavers that produce fabric for apparel, hosiery, home furnishings, automotive, industrial, and other end-use markets. Polyester yarns include partially oriented yarn (POY), textured, solution and package dyed, twisted, beamed, and draw wound yarns, and each is available in virgin or recycled varieties. UNIFI offers specialized yarns, premium value-added (PVA) yarns, and commodity yarns. The company's reportable segments are; the Americas, Brazil, and Asia. Its maximum revenue is derived from the Americas.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.